ACTUATE THERAPEUTICS, INC. (ACTU)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 4, 2025 | CORRESP | Neutral/Informational | Moderate | Actuate Therapeutics, Inc. has formally withdrawn its request for the acceleration of the effective date of its registration statement originally set for September 4, 2025. Instea… | Read Filing EDGAR |
| Sep. 2, 2025 | CORRESP | Neutral/Informational | Moderate | Actuate Therapeutics, Inc. has submitted a request to the SEC to accelerate the effective date of their registration statement on Form S-3 to September 4, 2025. The company acknow… | Read Filing EDGAR |
| Aug. 26, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Actuate Therapeutics, Inc. that they do not intend to review the company's draft registration statement submitted on August 18, 2025. The SEC has reque… | Read Filing EDGAR |
| Jul. 31, 2025 | CORRESP | Neutral/Informational | Moderate | Actuate Therapeutics, Inc. has submitted a request to the SEC to accelerate the effective date of their registration statement on Form S-1 to August 4, 2025. The company acknowled… | Read Filing EDGAR |
| Jul. 31, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Actuate Therapeutics, Inc. that they will not review the company's registration statement filed on July 25, 2025. The SEC emphasizes that the responsib… | Read Filing EDGAR |